Article: T3 therapy not yet ready for psychiatric use.(Adult Psychiatry)

VANCOUVER, B.C. -- Triiodothyronine therapy is most definitely not a treatment whose time has come, a panel of experts agreed at a satellite symposium held in conjunction with the annual meeting of the American Thyroid Association.

Despite more than 3 decades of psychiatric interest in using [T.sub.3] in the treatment of depression and more recent enthusiasm for [T.sub.3] in treating primary hypothyroidism and the euthyroid sick syndrome, none of these applications is supported by reasonable clinical data--and in the case of euthyroid sick syndrome, there is a distinct potential for harm, according to the panelists.

James V. Hennessey, M.D., observed ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!